Spectral Domain Optical Coherence Tomography Imaging of Dry Age-Related Macular Degeneration

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th St., Miami, FL 33136 , USA.
Ophthalmic Surgery Lasers and Imaging (Impact Factor: 1.32). 11/2010; 41 Suppl(6):S6-S14. DOI: 10.3928/15428877-20101031-19
Source: PubMed


Spectral domain optical coherence tomography is a useful new technology for imaging and measuring geographic atrophy (GA) and drusen, the hallmarks of dry age-related macular degeneration (AMD). The advantage of using this novel technique over other imaging modalities for dry AMD is that the same scan pattern can be used to image both drusen and GA while obtaining reproducible, quantitative data on both the area of GA and the morphologic features of drusen. Moreover, this strategy enables the clinician to follow the disease as it progresses from drusen to both GA and choroidal neovascularization. No other imaging modality is able to quantitatively assess all forms of AMD. This unique feature of spectral domain optical coherence tomography makes it the ideal imaging modality for clinical trials designed to assess new drugs for the treatment of dry AMD.

Download full-text


Available from: Fernando Marcondes Penha,
  • Source
    • "Although this is a remarkable advance with respect to previous generations of OCT instruments, it still represents a relatively small retinal area in absolute terms. It would clearly be clinically desirable to be able to image a wider FOV and investigate retinal features across large regions [1]. The main factor limiting the FOV is the scanning speed of the instrument, since the image acquisition time is constrained by the patient’s ability to fixate without eye movements (typically less than two seconds). "
    [Show abstract] [Hide abstract]
    ABSTRACT: This paper proposes an automatic algorithm for the montage of OCT data sets, which produces a composite 3D OCT image over a large field of view out of several separate, partially overlapping OCT data sets. First the OCT fundus images (OFIs) are registered, using blood vessel ridges as the feature of interest and a two step iterative procedure to minimize the distance between all matching point pairs over the set of OFIs. Then the OCT data sets are merged to form a full 3D montage using cross-correlation. The algorithm was tested using an imaging protocol consisting of 8 OCT images for each eye, overlapping to cover a total retinal region of approximately 50x35 degrees. The results for 3 normal eyes and 3 eyes with retinal degeneration are analyzed, showing registration errors of 1.5±0.3 and 2.0±0.8 pixels respectively.
    Optics Express 12/2011; 19(27):26239-48. DOI:10.1364/OE.19.026239 · 3.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper proposes an algorithm for retinal image registration involving OCT fundus images (OFIs). The first application of the algorithm is to register OFIs with color fundus photographs; such registration between multimodal retinal images can help correlate features across imaging modalities, which is important for both clinical and research purposes. The second application is to perform the montage of several OFIs, which allows us to construct 3D OCT images over a large field of view out of separate OCT datasets. We use blood vessel ridges as registration features. The brute force search and an Iterative Closest Point (ICP) algorithm are employed for image pair registration. Global alignment to minimize the distance between matching pixel pairs is used to obtain the montage of OFIs. Quality of OFIs is the big limitation factor of the registration algorithm. In the first experiment, the effect of manual OFI enhancement on registration was evaluated for the affine model on 11 image pairs from diseased eyes. The average root mean square error (RMSE) decreases from 58 mum to 40 mum. This indicates that the registration algorithm is robust to manual enhancement. In the second experiment for the montage of OFIs, the algorithm was tested on 6 sets from healthy eyes and 6 sets from diseased eyes, each set having 8 partially overlapping SD-OCT images. Visual evaluation showed that the montage performance was acceptable for normal cases, and not good for abnormal cases due to low visibility of blood vessels. The average RMSE for a typical montage case from a healthy eye is 2.3 pixels (69 mum).
    Proceedings of SPIE - The International Society for Optical Engineering 03/2011; 7962. DOI:10.1117/12.877697 · 0.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In recent years, the management of macular disease has undergone radical changes, in part because of new therapeutic approaches, but also due to the introduction of a new imaging modality - optical coherence tomography (OCT). The application of OCT imaging has clarified many aspects of chorioretinal disease pathophysiology and elucidated many hitherto unrecognized disease characteristics. From an early stage in its development, OCT has also been revolutionary in attempting to extract clinically useful measurements from image data in an automated fashion. As a result, OCT-derived measurements of retinal thickness have been rapidly embraced in clinical and research settings. However, as knowledge of OCT image analysis has developed, it has become increasingly clear that even accurate measurements of retinal thickness may fail to predict visual outcomes for many diseases. As a result, the focus of much current clinical imaging research is on the identification of other OCT-derived anatomic biomarkers predictive of visual outcomes - such biomarkers could serve as surrogate endpoints in clinical trials and provide prognostic information in clinical practice. In this review, we begin by highlighting the importance of accurate visual function assessment and describing the fundamentals of OCT image evaluation, before describing the current state-of-the-art with regard to predicting visual outcomes, for a variety of macular diseases, using OCT.
    Saudi Journal of Ophthalmology 04/2011; 25(2):145-58. DOI:10.1016/j.sjopt.2011.01.003
Show more